139 related articles for article (PubMed ID: 36399924)
1. Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents.
Courtens C; van Charante F; Quennesson T; Risseeuw M; Cos P; Caljon G; Coenye T; Van Calenbergh S
Eur J Med Chem; 2023 Jan; 245(Pt 1):114924. PubMed ID: 36399924
[TBL] [Abstract][Full Text] [Related]
2. Amino acid based prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
Courtens C; Risseeuw M; Caljon G; Maes L; Martin A; Van Calenbergh S
Bioorg Med Chem; 2019 Mar; 27(5):729-747. PubMed ID: 30692024
[TBL] [Abstract][Full Text] [Related]
3. Double prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
Courtens C; Risseeuw M; Caljon G; Maes L; Cos P; Martin A; Van Calenbergh S
Bioorg Med Chem Lett; 2019 May; 29(10):1232-1235. PubMed ID: 30879839
[TBL] [Abstract][Full Text] [Related]
4. Phosphonodiamidate prodrugs of N-alkoxy analogs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
Courtens C; Risseeuw M; Caljon G; Cos P; Martin A; Van Calenbergh S
Bioorg Med Chem Lett; 2019 May; 29(9):1051-1053. PubMed ID: 30857749
[TBL] [Abstract][Full Text] [Related]
5. Prodrugs of reverse fosmidomycin analogues.
Brücher K; Gräwert T; Konzuch S; Held J; Lienau C; Behrendt C; Illarionov B; Maes L; Bacher A; Wittlin S; Mordmüller B; Fischer M; Kurz T
J Med Chem; 2015 Feb; 58(4):2025-35. PubMed ID: 25633870
[TBL] [Abstract][Full Text] [Related]
6. Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity.
Wiesner J; Ortmann R; Jomaa H; Schlitzer M
Arch Pharm (Weinheim); 2007 Dec; 340(12):667-9. PubMed ID: 17994601
[TBL] [Abstract][Full Text] [Related]
7. Resistance to the antimicrobial agent fosmidomycin and an FR900098 prodrug through mutations in the deoxyxylulose phosphate reductoisomerase gene (dxr).
Armstrong CM; Meyers DJ; Imlay LS; Freel Meyers C; Odom AR
Antimicrob Agents Chemother; 2015 Sep; 59(9):5511-9. PubMed ID: 26124156
[TBL] [Abstract][Full Text] [Related]
8. A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling.
Zhang B; Watts KM; Hodge D; Kemp LM; Hunstad DA; Hicks LM; Odom AR
Biochemistry; 2011 May; 50(17):3570-7. PubMed ID: 21438569
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antimalarial evaluation of prodrugs of novel fosmidomycin analogues.
Faísca Phillips AM; Nogueira F; Murtinheira F; Barros MT
Bioorg Med Chem Lett; 2015; 25(10):2112-6. PubMed ID: 25881827
[TBL] [Abstract][Full Text] [Related]
10. MEPicides: α,β-unsaturated Fosmidomycin
Wang X; Edwards RL; Ball HS; Heidel KM; Brothers RC; Johnson C; Haymond A; Girma M; Dailey A; Roma JS; Boshoff HI; Osbourn DM; Meyers MJ; Couch RD; Odom John AR; Dowd CS
ACS Infect Dis; 2023 Jul; 9(7):1387-1395. PubMed ID: 37310810
[TBL] [Abstract][Full Text] [Related]
11. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase (IspC) from Mycobacterium tuberculosis: towards understanding mycobacterial resistance to fosmidomycin.
Dhiman RK; Schaeffer ML; Bailey AM; Testa CA; Scherman H; Crick DC
J Bacteriol; 2005 Dec; 187(24):8395-402. PubMed ID: 16321944
[TBL] [Abstract][Full Text] [Related]
12. Lipophilic prodrugs of FR900098 are antimicrobial against Francisella novicida in vivo and in vitro and show GlpT independent efficacy.
McKenney ES; Sargent M; Khan H; Uh E; Jackson ER; San Jose G; Couch RD; Dowd CS; van Hoek ML
PLoS One; 2012; 7(10):e38167. PubMed ID: 23077474
[TBL] [Abstract][Full Text] [Related]
13. Dxr is essential in Mycobacterium tuberculosis and fosmidomycin resistance is due to a lack of uptake.
Brown AC; Parish T
BMC Microbiol; 2008 May; 8():78. PubMed ID: 18489786
[TBL] [Abstract][Full Text] [Related]
14. Acyloxyalkyl ester prodrugs of FR900098 with improved in vivo anti-malarial activity.
Ortmann R; Wiesner J; Reichenberg A; Henschker D; Beck E; Jomaa H; Schlitzer M
Bioorg Med Chem Lett; 2003 Jul; 13(13):2163-6. PubMed ID: 12798327
[TBL] [Abstract][Full Text] [Related]
15. MEPicides: potent antimalarial prodrugs targeting isoprenoid biosynthesis.
Edwards RL; Brothers RC; Wang X; Maron MI; Ziniel PD; Tsang PS; Kraft TE; Hruz PW; Williamson KC; Dowd CS; John ARO
Sci Rep; 2017 Aug; 7(1):8400. PubMed ID: 28827774
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin.
Wiesner J; Henschker D; Hutchinson DB; Beck E; Jomaa H
Antimicrob Agents Chemother; 2002 Sep; 46(9):2889-94. PubMed ID: 12183243
[TBL] [Abstract][Full Text] [Related]
17. DXR inhibition by potent mono- and disubstituted fosmidomycin analogues.
Jansson AM; Więckowska A; Björkelid C; Yahiaoui S; Sooriyaarachchi S; Lindh M; Bergfors T; Dharavath S; Desroses M; Suresh S; Andaloussi M; Nikhil R; Sreevalli S; Srinivasa BR; Larhed M; Jones TA; Karlén A; Mowbray SL
J Med Chem; 2013 Aug; 56(15):6190-9. PubMed ID: 23819803
[TBL] [Abstract][Full Text] [Related]
18. Novel reverse thia-analogs of fosmidomycin: Synthesis and antiplasmodial activity.
Lienau C; Gräwert T; Alves Avelar LA; Illarionov B; Held J; Knaab TC; Lungerich B; van Geelen L; Meier D; Geissler S; Cynis H; Riederer U; Buchholz M; Kalscheuer R; Bacher A; Mordmüller B; Fischer M; Kurz T
Eur J Med Chem; 2019 Nov; 181():111555. PubMed ID: 31382119
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of Action of
Girma MB; Ball HS; Wang X; Brothers RC; Jackson ER; Meyers MJ; Dowd CS; Couch RD
ACS Omega; 2021 Oct; 6(42):27630-27639. PubMed ID: 34722963
[TBL] [Abstract][Full Text] [Related]
20. The non-mevalonate isoprenoid biosynthesis of plants as a test system for new herbicides and drugs against pathogenic bacteria and the malaria parasite.
Lichtenthaler HK; Zeidler J; Schwender J; Müller C
Z Naturforsch C J Biosci; 2000; 55(5-6):305-13. PubMed ID: 10928537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
